全文获取类型
收费全文 | 757篇 |
免费 | 0篇 |
专业分类
电工技术 | 2篇 |
化学工业 | 17篇 |
金属工艺 | 1篇 |
机械仪表 | 6篇 |
建筑科学 | 1篇 |
能源动力 | 3篇 |
轻工业 | 5篇 |
石油天然气 | 1篇 |
无线电 | 1篇 |
冶金工业 | 703篇 |
自动化技术 | 17篇 |
出版年
2018年 | 2篇 |
2013年 | 3篇 |
2012年 | 5篇 |
2011年 | 3篇 |
2010年 | 6篇 |
2009年 | 2篇 |
2008年 | 1篇 |
2007年 | 2篇 |
2006年 | 3篇 |
2005年 | 6篇 |
2003年 | 1篇 |
2002年 | 1篇 |
1999年 | 20篇 |
1998年 | 201篇 |
1997年 | 118篇 |
1996年 | 67篇 |
1995年 | 40篇 |
1994年 | 47篇 |
1993年 | 32篇 |
1992年 | 5篇 |
1991年 | 11篇 |
1990年 | 6篇 |
1989年 | 14篇 |
1988年 | 13篇 |
1987年 | 6篇 |
1986年 | 4篇 |
1985年 | 4篇 |
1983年 | 7篇 |
1982年 | 2篇 |
1981年 | 6篇 |
1980年 | 15篇 |
1979年 | 1篇 |
1978年 | 4篇 |
1977年 | 28篇 |
1976年 | 66篇 |
1975年 | 3篇 |
1972年 | 1篇 |
1955年 | 1篇 |
排序方式: 共有757条查询结果,搜索用时 31 毫秒
101.
102.
FA Anderson HB Wheeler RJ Goldberg DW Hosmer A Forcier NA Patwardhan 《Canadian Metallurgical Quarterly》1994,154(6):669-677
OBJECTIVE: To determine the effect of continuing medical education (CME) with and without a quality assurance component (CME+QA) on physician practices in the prevention of venous thromboembolism. METHODS: A communitywide study was performed in 15 short-stay hospitals in central Massachusetts. The study population included 3158 patients in acute-care hospitals with multiple risk factors for venous thromboembolism. Study hospitals were randomly assigned to one of two educational strategies or to a control group that received no intervention. RESULTS: The proportion of patients at high risk for venous thromboembolism who received effective methods of prophylaxis increased significantly from 29% in 1986 to 52% in 1989 (P < .001). This increase was seen in all study groups: control hospitals, 40% to 51% (P < .001); CME hospitals, 21% to 49% (P < .0001); and CME+QA hospitals, 27% to 55% (P < .0001). The increase in prophylaxis use from 1986 to 1989 was significantly greater among patients cared for in hospitals whose physicians participated in a formal CME program (an increase of 28%) than in control hospitals (an increase of 11%) (P < .001). There was no significant difference in the use of prophylaxis in hospitals whose physicians received CME+QA interventions compared with hospitals whose physicians received CME interventions alone (identical increases of 28%). CONCLUSION: A formal CME program significantly increased the frequency with which physicians prescribed prophylaxis for venous thromboembolism. We believe the key factor in our CME interventions that motivated clinicians to change their practices was the provision of hospital-specific data demonstrating a compelling need for improvement. Despite the substantial investment by hospitals in QA, traditional QA intervention appeared to provide no additional benefit. Even after extensive CME/QA interventions, prophylaxis for venous thromboembolism remained underutilized, suggesting the need to develop new approaches to changing clinical practice. 相似文献
103.
104.
105.
106.
107.
HF L?hr C Elste HP Dienes G Michel HB Braun KH Meyer zum Büschenfelde G Gerken 《Canadian Metallurgical Quarterly》1996,25(3):292-300
BACKGROUND/AIM: Virus-host interactions may have pathogenetic significance in chronic hepatitis. Thus the humoral immune response was evaluated during the clinical course of HCV-infected patients. METHODS: Eighteen selected chronic HCV patients received three doses of 3 or 6 MU interferon-alpha 2a weekly for 6 to 12 months and were followed up for 6 to 60 months. Anti-HCV antibody levels were serially measured either in end-point diluted sera with the Matrix-Assay or with quantitative anti-HC34-IgG and -IgM ELISA. Circulating immune complexes were assessed by flow cytometry and the results were correlated with histology, quantitative HCV-RNA levels and genotypes. RESULTS: Nine complete responders (CR; genotypes 1a n = 4; 1b n = 1; 2a n = 1; 3a n = 3) showing sustained virus elimination and ALT normalisation had low HCV-RNA pretreatment levels (mean 14 x 10(3) copies/ml) compared to six nonresponders and three partial responders (NR/PR; genotypes 1a n = 2; 1b n = 7) who had significantly higher HCV-RNA pretreatment levels (mean 254 x 10(3) copies/ml; p < 0.01). In untreated NR/PR the HC34 core-antigen was most immunogenic, in CR the NS3-derived HC29-antigen. Pre-treatment levels of anti-HC 34-IgG and -IgM antibody levels in NR/PR were higher than in CR (IgM/IgG p = 0.05, n.s.) and these differences became significant during or after therapy (3 months therapy: IgM p < 0.02/IgG p < 0.07; end of therapy: IgM 0.006/IgG p < 0.04; 6 months post-therapy: IgM p < 0.002/IgG p < 0.004). The PR patients showed recurrent anti-HC34 antibody levels that preceded disease reactivation and detectable HCV-RNA in serum. Immune complex formation increased in some patients during treatment but did not correlate with disease activity, quantitative viraemia, antibody levels or therapy outcome. CONCLUSION: Anti-HC34 antibodies, i.e. of the IgM-subtype, correlated quantitatively with viraemia and disease activity. Monitoring the antibody levels may predict the long-term therapy outcome during interferon-alpha treatment. 相似文献
108.
109.
HB Beverloo A van Schadewijk HJ Zijlmans NP Verwoerd J Bonnett H Vrolijk HJ Tanke 《Canadian Metallurgical Quarterly》1993,41(5):719-725
In Escherichia coli, UV and many chemicals appear to cause mutagenesis by a process of translesion synthesis that requires some form of DNA polymerase III and the SOS-regulated proteins UmuD, UmuC and RecA. An analysis of SOS mutagenesis offers insights into the molecular basis of induced mutagenesis and into mechanisms of DNA damage tolerance. 相似文献
110.
The authors present clinical and case material on two male triplets with aberrant gender identity. Their findings coincide with those of the few family studies reported in which there were two or more transsexual members; they also reveal patterns generally in keeping with the psychological determinants of transsexualism suggested by Stoller. 相似文献